The GSK3 hypothesis of Alzheimer's disease

1.0kCitations
Citations of this article
1.0kReaders
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Glycogen synthase kinase 3 (GSK3) is a constitutively active, proline-directed serine/threonine kinase that plays a part in a number of physiological processes ranging from glycogen metabolism to gene transcription. GSK3 also plays a pivotal and central role in the pathogenesis of both sporadic and familial forms of Alzheimer's disease (AD), an observation that has led us to coin the 'GSK3 hypothesis of AD'. According to this hypothesis, over-activity of GSK3 accounts for memory impairment, tau hyper-phosphorylation, increased β-amyloid production and local plaque-associated microglial-mediated inflammatory responses; all of which are hallmark characteristics of AD. If our 'GSK3 hypothesis of AD' is substantiated and GSK3 is indeed a causal mediator of AD then inhibitors of GSK3 would provide a novel avenue for therapeutic intervention in this devastating disorder. © 2008 The Authors.

Cite

CITATION STYLE

APA

Hooper, C., Killick, R., & Lovestone, S. (2008, March). The GSK3 hypothesis of Alzheimer’s disease. Journal of Neurochemistry. https://doi.org/10.1111/j.1471-4159.2007.05194.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free